Song Qian, Zhan Ying, Li Lu-jia
Department of Oncology, 401 Hospital of PLA, Qingdao 266071, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2006 Feb;26(2):229-30.
To evaluate the clinical efficacy of percutaneous targeted argon-helium cryoablation for soft tissue sarcoma and analyze the changes in CT findings and side effects in relation to the treatment.
Thirty-two patients with soft tissue sarcoma were treated with CT-guided argon-helium cryoablation.
Three months after the treatment, 52 tumors showed obvious reduction in size with a total complete and partial remission rate of 73.1%. Postoperative CT scanning displayed low-density local necrosis in the tumors after cryotherapy, and consolidation of the lesions was observed at 3 months and lesion disappearance at 1 year after the therapy. The complications included pneumothorax, coughing, hemoptysis, fever, and slight elevation of aminotransferase.
CT-guided percutaneous targeted argon-helium cryoablation is safe and effective for lung cancer with minimal invasions.
评估经皮靶向氩氦刀冷冻消融治疗软组织肉瘤的临床疗效，并分析其治疗前后CT表现及副作用的变化。
对32例软组织肉瘤患者采用CT引导下氩氦刀冷冻消融治疗。
治疗后3个月，52个肿瘤体积明显缩小，完全缓解和部分缓解率总计为73.1%。术后CT扫描显示冷冻治疗后肿瘤局部呈低密度坏死，治疗后3个月观察到病灶强化，1年后病灶消失。并发症包括气胸、咳嗽、咯血、发热及转氨酶轻度升高。
CT引导下经皮靶向氩氦刀冷冻消融治疗肺癌安全有效，创伤极小。
